Cholera Vaccine Market

Cholera Vaccine Market Size by Product Type (Dukoral, Vaxchora, Shanchol, Euvichol and Euvichol-Plus and Others), End User (Hospitals and Clinics, Research and Academic Laboratories, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13727
  • Published Date: Sep, 2023
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global cholera vaccine market was valued at USD 60 million in 2022 and grew at a CAGR of 10% from 2023 to 2032. The market is expected to reach USD 155.62 million by 2032. The increasing incidence of cholera outbreaks will drive the growth of the global cholera vaccine market.

Market Introduction:

Vaccine is a substance that boosts the immune system's defences against various illnesses. In simple terms, a vaccine is an inactivated virus or medication replicating the virus. It enables the body to identify the virus and activate an effective immune response against it, enabling future protection against the same virus. Most vaccines are given by needle injection. They are also administered through the nose. A vaccine goes through several tests, trials and experiments to ensure its efficacy, safety and applicability. It must be safe, effective, long-lasting and commercially viable to process and produce on a large scale for it to be effectively deployed in the real world. Vaccines are beneficial in preventing major illnesses, hospitalization, and death. They arrest the spread of virulent diseases by offering herd immunity to the community. Cholera is a contagious disease which results in severe acute watery diarrhoea and dehydration. Contaminated food or drink are the carriers of cholera. Cholera can be managed with medication and support; however, cholera can kill both adults and children within hours if left untreated. Rehydration, intravenous fluids, and antibiotics are used in treatment. A successful cholera vaccine offers about 85% protection for the first six months following immunization. The protection drops 50% or 62 per cent within the first year. The amount of protection falls to less than 50% after two years. Three oral cholera vaccines (OCV) have received WHO pre-qualification: Dukoral, ShancholTM, and Euvichol.

Cholera Vaccine Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • May 2022 - Days after the World Health Organisation warned that the short-term outlook for managing the disease was dire, a global vaccine alliance stated that a shortage of cholera vaccinations is expected to endure until 2025 as outbreaks spread globally. In a report, the Gavi Alliance, a global organization devoted to kid immunization, stated that there are now enough doses to meet emergency demand but not for preventative use. According to the report, when a new business joins the market, and existing manufacturers ramp up production, the supply should improve by 2026. It also urged greater planning to ensure vaccinations are used where they are most needed, such as for preventative campaigns.

Market Dynamics:

Drivers

The increasing incidence of cholera outbreaks – the under-developed nations of the world are riddled with extreme poverty, lack of access to clean water and food, unhygienic living surroundings and sub-par healthcare services. All these conditions are ideal for virulent diseases like cholera. Several cholera outbreaks have occurred in the African continent following a natural calamity like floods. Given the lack of healthcare or medical infrastructure, these conditions lead to preventable deaths. The international organizations underscored the importance of controlling these outbreaks and preventing deaths through immunization. Therefore, global cooperation has increased research, development, production, distribution and administration of cholera vaccines in these hotspots across continents. The growing emphasis on achieving sustainable development goals of health for all is driving the need to immunize the world against diseases like cholera. Therefore, the increasing incidence or outbreaks of cholera in under-developed regions of the world has increased the focus towards improving immunization, which will drive the global cholera vaccine market's growth. 

  • March 2023 - In conjunction with health authorities, the Syria Immunisation Group (SIG), and Gavi - the Vaccine Alliance, the World Health Organisation (WHO) and the United Nations Children's Fund (UNICEF) launched a cholera immunization campaign in earthquake-stricken regions of northwest Syria. To protect Syrians over the age of one, especially those residing in the regions most badly affected by the earthquake and at the greatest risk of contracting cholera, 1.7 million doses of the cholera vaccine will be administered during the campaign. The 10-day campaign will be carried out by 1400 teams of community volunteers and health workers who will go home to house to reach displaced persons residing in camps, marketplaces, and school locations.
Restraints:

The high development costs developing a vaccine for any disease takes years of research. The research is followed by developing a sample vaccine, which goes through several stages of experiments, trials and testing to establish optimal efficacy, safety and viability. The efficacy is then verified by relevant regulatory authorities through an extensive and time-consuming process, giving the potential effect these vaccines have on human health. The several stages a vaccine goes through, from its development to production to its approval, is a time-consuming, capital-intensive process. Therefore, the high costs of development lead to high retail costs of vaccines, which become unaffordable for most of the population if not offered through government hospitals free-of-costs or at subsidized rates. Therefore, the high development costs will restrict the market's growth.

Opportunities:

The increasing research, development and innovation the increasing demand for cholera vaccines given the rising incidence of cholera has led to a growing need to develop innovative methods to quickly manufacture, distribute and administer cholera vaccines. The shortage of vaccine manufacturing capabilities has prompted market players and international organizations to collaborate to meet the supply-demand shortage. The collaborations and partnerships will lead to improved products, vaccines, manufacturing processes, and supply-chain systems, ensuring last-mile delivery of quality vaccines across the globe. Therefore, the increasing research development and innovation facilitated by collaborations and partnerships will drive the market’s growth during the forecast period.

  • May 2023 - The world's first and only oral cholera vaccine (OCV), Euvichol-Plus, was introduced in India by Mumbai-based firm TechInvention Lifecare in collaboration with Eubiologics Co. in South Korea. It comes in a low-density polyethylene (LDPE) unidose pack. The Euvichol-Plus LDPE unidose pack is simple and secure to use, but it also lessens the problems associated with traditional glass vials regarding breakage, storage, distribution, and waste management. It also makes delivering in emergency situations and humanitarian crises easier in campaign mode. Following the conclusion of a phase III clinical trial, TechInvention got approval from the regulatory authority Central Drugs Standard Control Organisation (CDSCO) to introduce Euvichol-Plus.
Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. Asia Pacific emerged as the most significant global cholera vaccine market, with a 35% market revenue share in 2022.

Cholera is prevalent in Southeast Asian nations, given the significant proportion of the impoverished population with a lack of clean water and food access. The increasing research and development expenditure by the government to produce indigenous vaccines will bode well for the market. The established pharmaceuticals and their manufacturing capabilities in the region will augment vaccine production and drive the regional market's growth. 

Asia Pacific Region Cholera Vaccine Market Share in 2022 - 35%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • August 2023 - A Memorandum of Understanding (MOU) for the combined production of the oral cholera vaccine Euvichol by Eubiologics and South Korean biopharmaceutical company GC Biopharma has been inked. According to the agreement, both businesses will work together to supply vaccines. While GC Biopharma will be in charge of packaging, including vial bottling, Eubiologics will oversee the bulk manufacturing of the vaccine. Beginning in the first half of 2024, the parties will work together to manufacture Euvichol for supply to UNICEF, the United Nations International Children's Emergency Fund. To combat the current development of the cholera infection in various locations, such as Africa, UNICEF has sought out more supplies of vaccinations besides those of a plastic-tubed Euvichol-Plus.
Product type Segment Analysis

The product type segment is divided into Dukoral, Vaxchora, Shanchol, Euvichol and Euvichol-Plus and others. The Dukoral segment dominated the market, with a market share of around 40% in 2022. A vaccine called Dukoral is administered orally to prevent cholera. It is the prescribed choice for People who travel to cholera outbreak hotspots. It is used in children as young as 2. For the first five months, Dukoral's preventive efficacy is 85%. A booster dose offers 61% protection over an extended period.

End-user Segment Analysis

The end user class segment is divided into hospitals and clinics, research and academic laboratories, and others. The hospitals and clinics segment dominated the market, with a share of around 59% in 2022. Hospitals and clinics, especially those run by the government, are the primary care-giving centres, including administering vaccinations. The immunization drives by governments are executed through hospitals and clinics. They have the necessary infrastructure to store, distribute and administer the vaccine. They have trained staff to deal with vaccination drives and any mild symptoms that may occur after administrating the vaccine.

  • August 2023 - During a 10-day oral cholera vaccine (OCV) campaign, Kenya exceeded its goal of immunizing 1.59 million individuals in eight high-risk counties. In partnership with county governments, the Health Ministry is enhancing coordination efforts, water, sanitation, and hygiene initiatives, risk communication networks, community participation, patient case management, and laboratory confirmation of cases. Kenya received 1.7 million vaccine doses and more for the OCV campaign from the International Coordinating Group (ICG) and the National Vaccines and Immunisation Programme of the Health Ministry. A further supply of 1.6 million doses from Gavi and the ICG was also sent in January 2023 to aid the nation in containing the outbreak.
Some of the Key Market Players:
  • Celldex Therapeutics, Inc.
  • Johnson & Johnson
  • Emergent BioSolutions, Inc.
  • Sanofi
  • Eubiologics Co., Ltd.
  • Astellas Pharma, Inc.
  • GlaxoSmithKline LLC
  • Pfizer Inc.
  • Merck and Co. Inc.
  • Takeda Pharmaceutical Company Ltd.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 60 Million
Market size value in 2032 USD 155.62 Million
CAGR (2023 to 2032) 10%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product Type and End-User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global cholera vaccine market was valued at USD 60 million in 2022 to USD 155.62 million by 2032.

Global cholera vaccine market is growing at a CAGR of 10% during the forecast period 2023-2032.

The market's growth will be influenced by the increasing incidence of cholera outbreaks.

The high development costs could hamper the market growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product Type
          4.3.2. Market Attractiveness Analysis By End-User
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing incidence of cholera outbreaks
    5.3. Restraints
          5.3.1. The high development costs
    5.4. Opportunities
          5.4.1. The increasing research, development and innovation
    5.5. Challenges
          5.5.1. The shortage of vaccines

6. Global Cholera Vaccine Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Dukoral
    6.3. Vaxchora
    6.4. Shanchol
    6.5. Euvichol and Euvichol-Plus
    6.6. Others

7. Global Cholera Vaccine Market Analysis and Forecast, By End-User
    7.1. Segment Overview
    7.2. Hospitals and Clinics
    7.3. Research and Academic Laboratories
    7.4. Others

8. Global Cholera Vaccine Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Cholera Vaccine Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Cholera Vaccine Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Celldex Therapeutics, Inc.
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Johnson & Johnson
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Emergent BioSolutions, Inc.
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Sanofi
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Eubiologics Co., Ltd.
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Astellas Pharma, Inc.
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. GlaxoSmithKline LLC
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Pfizer Inc.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Merck and Co. Inc.
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Takeda Pharmaceutical Company Ltd.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Component Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
 

List of Table

1. Global Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

2. Global Dukoral Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

3. Global Vaxchora Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

4. Global Shanchol Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

5. Global Euvichol and Euvichol-Plus Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

6. Global Others Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

7. Global Cholera Vaccine Market, By End User, 2019-2032 (USD Million) 

8. Global Hospitals and Clinics Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

9. Global Research and Academic Laboratories Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

10. Global Others Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

11. Global Cholera Vaccine Market, By Region, 2019-2032 (USD Million) 

12. North America Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

13. North America Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

14. U.S. Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

15. U.S. Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

16. Canada Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

17. Canada Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

18. Mexico Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

19. Mexico Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

20. Europe Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

21. Europe Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

22. Germany Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

23. Germany Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

24. France Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

25. France Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

26. U.K. Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

27. U.K. Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

28. Italy Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

29. Italy Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

30. Spain Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

31. Spain Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

32. Asia Pacific Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

33. Asia Pacific Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

34. Japan Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

35. Japan Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

36. China Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

37. China Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

38. India Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

39. India Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

40. South America Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

41. South America Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

42. Brazil Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

43. Brazil Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

44. Middle East and Africa Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

45. Middle East and Africa Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

46. UAE Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

47. UAE Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

48. South Africa Cholera Vaccine Market, By Product Type, 2019-2032 (USD Million) 

49. South Africa Cholera Vaccine Market, By End-User, 2019-2032 (USD Million) 

List of Figures 

1. Global Cholera Vaccine Market Segmentation

2. Cholera Vaccine Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Cholera Vaccine Market Attractiveness Analysis By Product Type

9. Global Cholera Vaccine Market Attractiveness Analysis By End-User

10. Global Cholera Vaccine Market Attractiveness Analysis By Region

11. Global Cholera Vaccine Market: Dynamics

12. Global Cholera Vaccine Market Share by Product Type (2022 & 2032)

13. Global Cholera Vaccine Market Share by End-User (2022 & 2032)

14. Global Cholera Vaccine Market Share by Regions (2022 & 2032)

15. Global Cholera Vaccine Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global cholera vaccine market based on below mentioned segments:

Global Cholera Vaccine Market by Product Type:

  • Dukoral
  • Vaxchora
  • Shanchol
  • Euvichol and Euvichol-Plus
  • Others

Global Cholera Vaccine Market by End-User:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

Global Cholera Vaccine Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date